Welcome!

News Feed Item

Colorectal Cancer Screening for African Americans: It's about Prevention, Not Just Detection

By the National Cancer Institute

BETHESDA, Md., April 3, 2014 /PRNewswire-USNewswire/ -- If a screening test could not only catch cancer early but also help to prevent it, could you think of any reason not to have the test?

Lifelines - from the National Cancer Institute.

All widely used cancer screening tests aim to detect cancer early, when treatment may be more successful. But several screening tests can also help find abnormal cells that have not yet become cancer, allowing them to be removed before they can cause problems. Colorectal cancer screening tests, for example, can help detect pre-cancerous growths called polyps. Removing these polyps prevents them from becoming cancer.

Colorectal cancer is the third most commonly diagnosed cancer in both African American men and women. More than 18,000 new cases of colorectal cancer are diagnosed in African Americans annually. And although colorectal cancer rates overall are declining in the United States, the rates for African Americans are decreasing more slowly than the rates for white Americans. African Americans are also more likely to be diagnosed when colorectal cancer is advanced and, therefore, less treatable.

Between 2002 and 2008, the likelihood of surviving 5 years after a diagnosis of colorectal cancer was only 57 percent for African Americans, compared with 65 percent for white Americans. The difference between African Americans and whites in colorectal cancer survival rates has actually widened over the years. For example, the American Cancer Society recently reported that, for patients with advanced colorectal cancer, 5-year survival rates among African Americans rose from 8.6 percent in 1992-1997 to just 9.8 percent in 2004-2009, whereas among whites they rose from 9.8 percent in 1992-1997 to 15.7 percent in 2004-2009.

Although many factors underlie these disparities, an important one is that African Americans are less likely to be screened for colorectal cancer than whites. For example, in 2010, only 56 percent of African American men and women over the age of 50 had been recently screened for colorectal cancer, compared with 62 percent of white Americans.

A large 2005 survey carried out by the National Cancer Institute, called the Health Information National Trends Survey, found that many African Americans do not know that, when colorectal cancer is caught early, survival rates are good. In fact, surgery can cure about 90 percent of people with early-stage colorectal cancer.

Several effective options for colorectal cancer screening exist, which means that you can find a test that fits your risk, your concerns, and your comfort level. Knowing your options can make it easier for you to ask your doctor for more information.

Colonoscopy and sigmoidoscopy: For these tests, a doctor uses a flexible lighted instrument to physically check the colon and remove any abnormal growths.

Colonoscopy checks the rectum and the entire colon. Your doctor will give you special laxative medications to take before colonoscopy to clean out your colon. You will generally have sedation (you will be given medications to make you sleep or be very relaxed during the procedure) for a colonoscopy. Current guidelines recommend that people at average risk of colorectal cancer have a colonoscopy every 10 years.

Sigmoidoscopy checks the rectum and the lower half of the colon (the sigmoid colon). The lower colon must be cleansed before sigmoidoscopy, but the preparation is less involved than that for colonoscopy. With sigmoidoscopy, you will usually not need sedation. Current guidelines recommend that people at average risk of colorectal cancer have a sigmoidoscopy every 5 years (with fecal occult blood tests every 3 years).

Fecal occult blood test/fecal immunochemical test (FOBT/FIT), also known as a stool test: For this test, your doctor gives you a kit to use at home to take one or more samples of stool. The samples are sent to the doctor's office or lab to be tested for traces of blood. Some people prefer the stool test because it is done in private, is inexpensive, doesn't require taking laxatives, and is simple to perform. Current guidelines recommend that people who choose FOBT/FIT screening have the test every year.

Most guidelines recommend that people at average risk of colorectal cancer begin screening at age 50 and continue until age 75. If you are over 50 and have never been screened for colorectal cancer, talk with your healthcare provider about which colorectal cancer screening test is right for you. You can also ask about lifestyle changes that may reduce your risk of the disease. If someone in your family has had colorectal polyps or cancer, you may need to start screening before age 50. Again, your healthcare provider is the place to start.

Not having health insurance can keep people from getting screened. If you are uninsured or underinsured, the Centers for Disease Control and Prevention has a program in 25 states that provides colorectal cancer screening services to low-income men and women aged 50–64 years. More information on this program can be found at cdc.gov/cancer/crccp. Under the Affordable Care Act, all Marketplace plans and many other plans must cover colorectal cancer screening for people over age 50 without charging a copayment or coinsurance.

To learn more about colorectal cancer, visit the National Cancer Institute (NCI) website at www.cancer.gov (search term: colorectal) or call 1-800-4-CANCER (1-800-422-6237). You can also visit NCI's new educational website on colorectal cancer screening, gutcheck.cancer.gov, or CDC's Screen for Life: National Colorectal Cancer Action Campaign (http://www.cdc.gov/cancer/colorectal/sfl/).

NCI leads the National Cancer Program and the NIH effort to dramatically reduce the burden of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. For more information about cancer, please visit the NCI web site at www.cancer.gov (or m.cancer.gov from your mobile device) or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). More articles and videos in the culturally relevant Lifelines series are available at www.cancer.gov/lifelines.

Logo - http://photos.prnewswire.com/prnh/20111018/DC89117LOGO

SOURCE National Cancer Institute

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Is advanced scheduling in Kubernetes achievable? Yes, however, how do you properly accommodate every real-life scenario that a Kubernetes user might encounter? How do you leverage advanced scheduling techniques to shape and describe each scenario in easy-to-use rules and configurations? In his session at @DevOpsSummit at 21st Cloud Expo, Oleg Chunikhin, CTO at Kublr, will answer these questions and demonstrate techniques for implementing advanced scheduling. For example, using spot instances ...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
SYS-CON Events announced today that Yuasa System will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Yuasa System is introducing a multi-purpose endurance testing system for flexible displays, OLED devices, flexible substrates, flat cables, and films in smartphones, wearables, automobiles, and healthcare.
SYS-CON Events announced today that CAST Software will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CAST was founded more than 25 years ago to make the invisible visible. Built around the idea that even the best analytics on the market still leave blind spots for technical teams looking to deliver better software and prevent outages, CAST provides the software intelligence that matter ...
SYS-CON Events announced today that Daiya Industry will exhibit at the Japanese Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Ruby Development Inc. builds new services in short period of time and provides a continuous support of those services based on Ruby on Rails. For more information, please visit https://github.com/RubyDevInc.
When it comes to cloud computing, the ability to turn massive amounts of compute cores on and off on demand sounds attractive to IT staff, who need to manage peaks and valleys in user activity. With cloud bursting, the majority of the data can stay on premises while tapping into compute from public cloud providers, reducing risk and minimizing need to move large files. In his session at 18th Cloud Expo, Scott Jeschonek, Director of Product Management at Avere Systems, discussed the IT and busine...
SYS-CON Events announced today that Evatronix will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Evatronix SA offers comprehensive solutions in the design and implementation of electronic systems, in CAD / CAM deployment, and also is a designer and manufacturer of advanced 3D scanners for professional applications.
As businesses evolve, they need technology that is simple to help them succeed today and flexible enough to help them build for tomorrow. Chrome is fit for the workplace of the future — providing a secure, consistent user experience across a range of devices that can be used anywhere. In her session at 21st Cloud Expo, Vidya Nagarajan, a Senior Product Manager at Google, will take a look at various options as to how ChromeOS can be leveraged to interact with people on the devices, and formats th...
First generation hyperconverged solutions have taken the data center by storm, rapidly proliferating in pockets everywhere to provide further consolidation of floor space and workloads. These first generation solutions are not without challenges, however. In his session at 21st Cloud Expo, Wes Talbert, a Principal Architect and results-driven enterprise sales leader at NetApp, will discuss how the HCI solution of tomorrow will integrate with the public cloud to deliver a quality hybrid cloud e...
DevOps at Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to w...
DevOps is under attack because developers don’t want to mess with infrastructure. They will happily own their code into production, but want to use platforms instead of raw automation. That’s changing the landscape that we understand as DevOps with both architecture concepts (CloudNative) and process redefinition (SRE). Rob Hirschfeld’s recent work in Kubernetes operations has led to the conclusion that containers and related platforms have changed the way we should be thinking about DevOps and...
SYS-CON Events announced today that Taica will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Taica manufacturers Alpha-GEL brand silicone components and materials, which maintain outstanding performance over a wide temperature range -40C to +200C. For more information, visit http://www.taica.co.jp/english/.
When it comes to cloud computing, the ability to turn massive amounts of compute cores on and off on demand sounds attractive to IT staff, who need to manage peaks and valleys in user activity. With cloud bursting, the majority of the data can stay on premises while tapping into compute from public cloud providers, reducing risk and minimizing need to move large files. In his session at 18th Cloud Expo, Scott Jeschonek, Director of Product Management at Avere Systems, discussed the IT and busine...
SYS-CON Events announced today that SourceForge has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. SourceForge is the largest, most trusted destination for Open Source Software development, collaboration, discovery and download on the web serving over 32 million viewers, 150 million downloads and over 460,000 active development projects each and every month.
Enterprises have taken advantage of IoT to achieve important revenue and cost advantages. What is less apparent is how incumbent enterprises operating at scale have, following success with IoT, built analytic, operations management and software development capabilities – ranging from autonomous vehicles to manageable robotics installations. They have embraced these capabilities as if they were Silicon Valley startups. As a result, many firms employ new business models that place enormous impor...